Improving Performance in Drivers With Mild Cognitive Impairment
1 other identifier
interventional
66
1 country
1
Brief Summary
The objective of this study is to assess the effectiveness of an intervention to address both executive function and processing speed changes that contribute to poor driving performance in adults with Mild Cognitive Impairment (MCI). Our hypotheses are that the study intervention will improve performance on a driving simulator and will improve (i) executive function, specifically attention and planning, (ii) useful field of view, (iii) mood, (iv) quality of life, and (v) reported motor vehicle crashes and driving infractions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 15, 2013
CompletedFirst Posted
Study publicly available on registry
September 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedJanuary 21, 2020
January 1, 2020
5.6 years
August 15, 2013
January 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Driving Performance
Measurements obtained on a computer-based driving simulation
9-14 weeks
Driving Performance
Measurements obtained on a computer-based driving simulation
33-38 weeks
Secondary Outcomes (7)
Sustained Attention to Response Task (SART)
9-14 weeks, 33-38 weeks
D-KEFs Tower Test
9-14 weeks, 33-38 weeks
Useful Field of View Test (UFOV)
9-14 weeks, 33-38 weeks
Cognitive Failures Questionnaire
9-14 weeks, 33-38 weeks
Dysexecutive Questionnaire
9-14 weeks, 33-38 weeks
- +2 more secondary outcomes
Study Arms (3)
Goal Management Training + Processing Speed Training
EXPERIMENTALGroup receives both Goal Management Training and as well as Processing Speed Training using DriveSharp software.
Processing Speed Training + Brain Health Workshop
ACTIVE COMPARATORGroup receives both Processing Speed Training (using DriveSharp) and participates in a Brain Health Workshop that is matched to Goal Management Training for session length and contact with trainer.
Brain Health Workshop + computer assignments
PLACEBO COMPARATORGroup participates in Brain Health Workshop and is provided with computer assignments to match for time spent on the computer in the other arms.
Interventions
9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
9 weeks, a total of 10 hours of computer-based processing speed training; 60-75 minutes/week
9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Eligibility Criteria
You may qualify if:
- mild cognitive impairment
- currently driving or voluntarily stopped driving within the past year
- fluent in English
You may not qualify if:
- visual problems that cannot be corrected with standard lenses
- alcohol/substance abuse
- stroke with residual motor /sensory deficit
- traumatic brain injury
- seizure in the past two years
- Parkinson's disease
- Multiple sclerosis
- untreated sleep apnea
- history of motion sickness
- history of dizziness, vertigo
- active primary psychiatric disorder requiring treatment
- on a dose of cognitive enhancing medication for less than 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baycrestlead
- Unity Health Torontocollaborator
- Sunnybrook Health Sciences Centrecollaborator
- Lakehead Universitycollaborator
- McGill Universitycollaborator
- University Health Network, Torontocollaborator
- Michael Garron Hospitalcollaborator
- Centre for Addiction and Mental Healthcollaborator
Study Sites (1)
Baycrest Health Sciences
Toronto, Ontario, M6A 2E1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary Naglie, MD
Baycrest
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Medicine
Study Record Dates
First Submitted
August 15, 2013
First Posted
September 5, 2013
Study Start
August 1, 2013
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
January 21, 2020
Record last verified: 2020-01